期刊
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
卷 15, 期 9, 页码 1143-1158出版社
TAYLOR & FRANCIS AS
DOI: 10.1586/14737159.2015.1059278
关键词
communicable diseases; early diagnosis; host-pathogen interactions; metabolome; molecular diagnostics; proteome; respiratory tract infection; sepsis; transcriptome; tuberculosis
类别
资金
- NIAID
- Henry Jackson Foundation
- Novartis
- DARPA
- Veteran's Affairs Center [1IK2CX000611]
- Novartis Diagnostics
- BioFire
- bioMerieux
- Nanosphere
A century of advances in infectious disease diagnosis and treatment changed the face of medicine. However, challenges continue to develop including multi-drug resistance, globalization that increases pandemic risks and high mortality from severe infections. These challenges can be mitigated through improved diagnostics, focusing on both pathogen discovery and the host response. Here, we review how 'omics' technologies improve sepsis diagnosis, early pathogen identification and personalize therapy. Such host response diagnostics are possible due to the confluence of advanced laboratory techniques (e.g., transcriptomics, metabolomics, proteomics) along with advanced mathematical modeling such as machine learning techniques. The road ahead is promising, but obstacles remain before the impact of such advanced diagnostic modalities is felt at the bedside.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据